Matthew Richard Moore

Insider Reports History

Entity
Individual
Location
C/O Arcutis Biotherapeutics, Inc., 3027 Townsgate Road, Suite 300, Westlake Village, CA
Signature
/s/ Martin D. Auster, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew Richard Moore:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Arcutis Biotherapeutics, Inc. SVP and Chief Business Officer Common Stock 146K $1.27M $8.74 May 2, 2024 Direct
Ventyx Biosciences, Inc. Chief Operating Officer Stock Option (Right to Buy) 320K May 16, 2024 Direct
Arcutis Biotherapeutics, Inc. SVP and Chief Business Officer Stock Option (Right to Buy) 0 Feb 13, 2024 Direct

Insider Reports Filed by Matthew Richard Moore

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VTYX Ventyx Biosciences, Inc. May 16, 2024 1 $0 4 May 17, 2024 Chief Operating Officer
VTYX Ventyx Biosciences, Inc. May 16, 2024 0 $0 3 May 17, 2024 Chief Operating Officer
ARQT Arcutis Biotherapeutics, Inc. May 1, 2024 2 -$40.9K 4 May 3, 2024 SVP and Chief Business Officer
ARQT Arcutis Biotherapeutics, Inc. Mar 4, 2024 1 -$38.6K 4 Mar 6, 2024 SVP and Chief Business Officer
ARQT Arcutis Biotherapeutics, Inc. Feb 13, 2024 10 $0 4 Feb 15, 2024 SVP and Chief Business Officer
ARQT Arcutis Biotherapeutics, Inc. Jan 12, 2024 2 $0 4 Jan 17, 2024 SVP and Chief Business Officer
ARQT Arcutis Biotherapeutics, Inc. Aug 29, 2023 1 $0 4 Sep 12, 2023 SVP and Chief Business Officer
ARQT Arcutis Biotherapeutics, Inc. Mar 2, 2023 4 -$25.5K 4 Mar 6, 2023 Reporting Person's title: Senior Vice President and Chief Business Officer
ARQT Arcutis Biotherapeutics, Inc. Mar 3, 2022 2 $0 4 Mar 7, 2022 SVP and Chief Business Officer